xCystence Bio

xCystence Bio is developing and optimising new, safe and effective drugs that prevent the formation of new cysts and the growth of existing ones in patients with polycystic kidney disease (PKD). In preventing or slowing disease progression, these therapies have the potential to significantly improve quality of life for those living with PKD.

Lead Researchers: Ian Smyth (MNHS) and Paul Stupple (MIPS)